BDX
BDX clinical trials: BECTON DICKINSON & CO
Every trial on ClinicalTrials.gov where BECTON DICKINSON & CO is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 90
- Trials linked
- 61
- As lead sponsor
- 29
- As collaborator
- 2
- Primary completions as lead sponsor, next 90 days
BDX on the catalyst calendar · BDX registry changes
- Primary completion Jun 30, 2027Sponsor estimateNo phase registeredNCT07798128Evaluation of Catheter Utilization in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External CatheterBecton, Dickinson and Company · Urinary IncontinenceNot yet recruitingBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimateNo phase registeredNCT07148323HemoSphere Alta StudyBecton, Dickinson and Company · Hemodynamic InstabilityRecruitingBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimateNo phase registeredNCT07555548UK PureWick™ At-Home Pilot StudyBecton, Dickinson and Company · Urinary IncontinenceRecruitingBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 5, 2026ActualNo phase registeredNCT07317648ClearSight NextGen1 StudyBecton, Dickinson and Company · Blood PressureCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT07216573The Continuity StudyBecton, Dickinson and Company · Blood PressureRecruitingBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT06492746Personal BP - CAI StudyBecton, Dickinson and Company · Blood PressureRecruitingBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 27, 2025ActualNo phase registeredNCT05957406SMART TRENDS StudyBecton, Dickinson and Company · Moderate to High-risk Noncardiac SurgeryCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2026ActualNo phase registeredNCT06604026Investigational Study With the BD PosiFlush™ SafeScrub on NADsBecton, Dickinson and Company · CRBSI - Catheter Related Bloodstream InfectionCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 23, 2025ActualNo phase registeredNCT06632496BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical StudyBecton, Dickinson and Company · BD Prevue II for Peripheral Intravenous Catheter PlacementCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 9, 2026ActualNo phase registeredNCT06632509BD SiteRite(TM) 9 Ultrasound System - Clinical StudyBecton, Dickinson and Company · BD SiteRite 9 for VAD InsertionCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 28, 2024ActualNo phase registeredNCT05953363Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.Becton, Dickinson and Company · AnesthesiaCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 23, 2025ActualNo phase registeredNCT06426121Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent ProductBecton, Dickinson and Company · SepsisCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 26, 2024ActualNo phase registeredNCT04461678Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay KitBecton, Dickinson and Company · Cervical CancerCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 8, 2023ActualNo phase registeredNCT05553418Investigational On-body Injector Clinical StudyBecton, Dickinson and Company · Healthy VolunteersCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 22, 2023ActualNo phase registeredNCT05130762A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free ConnectorsBecton, Dickinson and Company · Catheter Related ComplicationCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 8, 2024ActualNo phase registeredNCT05557422BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.Becton, Dickinson and Company · Chronic Lymphoproliferative Diseases (CLPD)CompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2012ActualNo phase registeredNCT01231984Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen NeedlesBecton, Dickinson and Company · Diabetes Mellitus, Type 1CompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 29, 2024ActualNo phase registeredNCT05035615Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow CytometerBecton, Dickinson and Company · Acute LeukemiaCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 26, 2023ActualNo phase registeredNCT05763147Study of BD Pre-filled Flush Syringes in ChinaBecton, Dickinson and Company · Effectiveness and Safety of Pre-filled Flush SyringeCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 12, 2021ActualNo phase registeredNCT04344314Impact of PIVC Length and Gauge on Catheter Indwell TimeBecton, Dickinson and Company · Indication for Peripheral Intravenous CatheterisationCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 22, 2022ActualNo phase registeredNCT05214560Prospective Clinical Evaluation of BD Spinal NeedlesBecton, Dickinson and Company · AnalgesiaCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 5, 2022ActualNo phase registeredNCT04263649Prospective Observational Study of the Power PICC Family of Devices and AccessoriesBecton, Dickinson and Company · Peripherally Inserted Central CatheterCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 29, 2023ActualNo phase registeredNCT05032313Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow CytometerBecton, Dickinson and Company · Chronic Lymphoproliferative Diseases (CLPD)CompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 24, 2022ActualNo phase registeredNCT05186311BD MiniDraw™ Capillary System Clinical Equivalence StudyBecton, Dickinson and Company · HealthyCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 25, 2023ActualNo phase registeredNCT05032339Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow CytometerBecton, Dickinson and Company · Plasma Cell DisorderCompletedBDXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 65 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner